Union, NJ, United States of America

Dasong Wang

This inventor holds 3 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dasong Wang. Retrieved from https://idiyas.com/inventor/dasong-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Dasong Wang

Introduction

Dasong Wang is a notable inventor based in Union, NJ (US). He has made significant contributions to the field of neurokinin antagonists, holding a total of 3 patents. His work is recognized for its potential impact on therapeutic applications.

Latest Patents

Among his latest patents, Dasong Wang has developed innovative compounds titled "Substituted oximes and hydrazones as neurokinin antagonists." This work showcases his dedication to advancing medical science and improving treatment options.

Career Highlights

Dasong Wang is currently employed at Schering Corporation, where he continues to push the boundaries of pharmaceutical research. His expertise in neurokinin antagonists positions him as a valuable asset in the industry.

Collaborations

Dasong has collaborated with esteemed colleagues such as Gregory A. Reichard and Neng-Yang Shih. These partnerships enhance the collaborative spirit of innovation within his field.

Conclusion

Dasong Wang's contributions to the field of neurokinin antagonists exemplify the importance of innovation in medicine. His work not only reflects his expertise but also his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…